Low-dose rituximab in autoimmune hemolytic anemia: 10 years after

Blood. 2019 Feb 28;133(9):996-998. doi: 10.1182/blood-2018-12-885228. Epub 2019 Jan 22.

Authors

Bruno Fattizzo¹, Anna Zaninoni¹, Loredana Pettine¹, Francesca Cavallaro¹, Eros Di Bona², Wilma Barcellini¹

Affiliations

¹ Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano-UOC Ematologia, Milan, Italy; and.
² Ematologia, Ospedale S. Bortolo, Vicenza, Italy.

PMID: 30670440
DOI: 10.1182/blood-2018-12-885228

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anemia, Hemolytic, Autoimmune*
Antibodies, Monoclonal, Murine-Derived
Humans
Rituximab

Substances

Antibodies, Monoclonal, Murine-Derived
Rituximab